Related Experiment Video
Updated: Nov 16, 2025
07:38
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
444
Autophagy Gene Panel-Based Prognostic Model in Myelodysplastic Syndrome
Ming-Jing Wang1,2, Wei-Yi Liu1, Xue-Ying Wang1,3
1Department of Hematology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Frontiers in Oncology
|February 22, 2021
Summary
Autophagy-related genes (ARGs) impact myelodysplastic syndrome (MDS) prognosis. A new seven-ARG score predicts patient survival, aiding personalized MDS treatment strategies.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Abnormal autophagy is implicated in myelodysplastic syndrome (MDS) pathogenesis and symptoms.
- The prognostic role of autophagy-related genes (ARGs) in MDS is not well understood.
Purpose of the Study:
- To investigate the prognostic significance of autophagy-related genes (ARGs) in myelodysplastic syndrome (MDS).
- To develop a predictive model for MDS patient survival based on ARGs.
Main Methods:
- Gene expression profiling of 108 MDS patients from the GSE58831 dataset.
- Identification of survival-associated genes and selection of seven key ARGs.
- Calculation of an Autophagy-related Prognostic Index (API) and patient risk stratification.
Main Results:
- Seven ARGs were identified as significantly associated with overall survival in MDS patients.
- A higher API score correlated with shorter overall survival in both training and validation cohorts.
- The API demonstrated independent prognostic value and showed potential in predicting MDS patient outcomes.
Conclusions:
- The identified seven ARGs and the derived API can effectively predict prognosis in MDS patients.
- This ARG-based prognostic model may guide individualized treatment strategies for MDS.
